Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Alastair Smith, Avacta Group CEO gives an Operational Update


Valirx Share Price (VAL)



Share Price Information for Valirx (VAL)


Share Price: 1.90Bid: 1.80Ask: 2.00Change: 0.10 (+5.56%)Riser - Valirx
Spread: 0.20Spread as %: 11.11%Open: 1.80High: 1.95Low: 1.70Yesterday’s Close: 1.80

Valirx Plc Ord 0.1P

Valirx is listed in the FTSE AIM All-Share
Valirx is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
1.90
Share Price SpacerBid
1.80
Share Price SpacerAsk
2.00
Share Price SpacerChange
5.56%0.10
Share Price SpacerVolume
2,639,307
Share Price SpacerOpen
1.80
Share Price SpacerHigh
1.95
Share Price SpacerLow
1.70
Share Price SpacerClose
1.80
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 454.96m £8.64m 30,000

52 Week High 7.73 52 Week High Date 12-DEC-2017
52 Week Low 0.90 52 Week Low Date 20-NOV-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
33 423,464 1,765,843 -1.000 -1.90 0.00 0.00


London South East Users info for Valirx




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Sep-18
16:25:30
1.99
115,000
Buy* 
1.80
2.00
2,289
Trade Type:
Ordinary
NonProtected portfolio
Single protected transaction

20-Sep-18
16:19:03
1.95
50,974
Buy* 
1.80
2.00
993.99
Trade Type:
Ordinary

20-Sep-18
16:18:33
1.95
50,000
Buy* 
1.80
2.00
975.00
Trade Type:
Ordinary




View more Valirx trades >>

Directors Deals for Valirx (VAL)
Trade DateActionNotifierPriceCurrencyAmountHolding
15-Mar-17Placing
Trade Notifier Information for Valirx
Satu Vainikka held the position of CEO at Valirx at the time of this trade.
 Satu Vainikka
2.5GBX400,0001024909
15-Mar-17Placing
Trade Notifier Information for Valirx
Gerald Desler held the position of CFO at Valirx at the time of this trade.
 Gerald Desler
2.5GBX400,000941875
15-Mar-17Placing
Trade Notifier Information for Valirx
George Morris held the position of Non-Executive Director at Valirx at the time of this trade.
 George Morris
2.5GBX400,000988287
View more Valirx directors dealings >>


woody2002
Posts: 1,914
Opinion:No Opinion
Price:1.90
VAL 101
Today 17:29
Valirx are partnering with an American and Chinese outfits to enter into clinical trials. GM quoted in his previous video saying news released in Autumn. Hopefully more than 401 to help the SP here.
jjp1985
Posts: 450
Opinion:No Opinion
Price:1.90
RE: val
Today 17:09
Pharmaceutical deals aren't my forte unfortunately but from the research i have done stage 3 trials of the respiratory system cost $23-$27million so it's going to add substantial value to Valirx also i see licencing agreements being announced at the same time...
woody2002
Posts: 1,914
Opinion:No Opinion
Price:1.90
RE: What is VAL 401?
Today 17:06
Johan the SP hasnt suffered because of competitors, its because of funding issues and dilution. Nothing to do with the science...
flipsome
Posts: 531
Opinion:No Opinion
Price:1.90
RE: val
Today 16:46
Jjp

Would 18p not value at circa £70mil

Erm .....what are you expecting the JV to look like?!?!
johandesilva
Posts: 513
Opinion:No Opinion
Price:1.90
RE: What is VAL 401?
Today 15:51
I presume immunotherapy based treatments are still done after chemotherapy and regression. Sadly chemotherapy is not going to go away because of immunotherapy development, is it?
View more share chat for Valirx (VAL) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.